AllSight
Companies · CC · Chemicals & Allied Products

Chemours Co (CC)

Chemours Co (CC) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Chemours Co (CC) stock — financials & valuation

Key numbers for Chemours Co (CC): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 44/100 — a percentile rank of Chemours Co’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.

Market cap$2.0B
P / S0.3×
EV / EBITDA21.4×
Gross margin15.3%
Operating margin-1.7%
Net margin-5.3%
Return on equity620.4%
ROIC-24.3%
Revenue growth-0.9%
Debt / equity-79.0×
Dividend yield2.6%

Is Chemours Co overvalued? P/S looks undervalued vs its 5-year range; EV/EBITDA looks fair vs its 5-year range.

Independent of the events above — derived from Chemours Co’s own financial statements and shown as context, never as advice.

Sep 10, 2026$455M settlement
Chemours settles North Carolina PFAS claims for $455M, gains liability clarity
Sep 9, 2026No new info
Chemours’ AI-infrastructure pitch expands, but the investor deck brings no fresh catalyst
Aug 4, 2026
Revenue missed consensus as EBITDA hit the high end; outlook stayed put.
Related companies in Chemicals & Allied Products
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact